Annamiacids A and B: Two dissymmetric bis-diterpenes containing a rare ketal-γ-lactone motif from Podocarpus annamiensis and their inhibitory effects on ATP-citrate lyase
Chi Song , Ze-Yu Zhao , Jin-Xin Zhu , Yi Zang , Juan Xiong , Jia Li , Jin-Feng Hu
{"title":"Annamiacids A and B: Two dissymmetric bis-diterpenes containing a rare ketal-γ-lactone motif from Podocarpus annamiensis and their inhibitory effects on ATP-citrate lyase","authors":"Chi Song , Ze-Yu Zhao , Jin-Xin Zhu , Yi Zang , Juan Xiong , Jia Li , Jin-Feng Hu","doi":"10.1016/j.phytol.2024.04.010","DOIUrl":null,"url":null,"abstract":"<div><p>Two undescribed dissymmetric <em>bis</em>-diterpenes, annamiacids A (<strong>1</strong>) and B (<strong>2</strong>), were isolated from the renewable twigs and leaves of <em>Podocarpus annamiensis,</em> a ‘vulnerable’ conifer endemic to China. Their structures and absolute configurations were determined by spectroscopic and computational methods. The homodimeric (abietane-<em>O</em>-abietane, <strong>1</strong>) and heterodimeric (abietane-<em>O</em>-totarane, <strong>2</strong>) dimers were constructed from an identical phenolic abietane unit through an ether linkage with a phenolic abietane acid and a phenolic totarane acid, respectively. Both comprise a rare intramolecular 6-ketal-19,6-<em>γ</em>-lactone motif. Compound <strong>2</strong> could significantly inhibit ATP-citrate lyase with an IC<sub>50</sub> value of 5.92 <em>μ</em>M. A molecular docking study disclosed alternative H-bonds/interacting amino acid residues and binding pockets between <strong>2</strong> and the ACL enzyme when compared with those of compound <strong>1</strong>, which supports their <em>in vitro</em> data.</p></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"61 ","pages":"Pages 142-148"},"PeriodicalIF":1.3000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390024000636","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Two undescribed dissymmetric bis-diterpenes, annamiacids A (1) and B (2), were isolated from the renewable twigs and leaves of Podocarpus annamiensis, a ‘vulnerable’ conifer endemic to China. Their structures and absolute configurations were determined by spectroscopic and computational methods. The homodimeric (abietane-O-abietane, 1) and heterodimeric (abietane-O-totarane, 2) dimers were constructed from an identical phenolic abietane unit through an ether linkage with a phenolic abietane acid and a phenolic totarane acid, respectively. Both comprise a rare intramolecular 6-ketal-19,6-γ-lactone motif. Compound 2 could significantly inhibit ATP-citrate lyase with an IC50 value of 5.92 μM. A molecular docking study disclosed alternative H-bonds/interacting amino acid residues and binding pockets between 2 and the ACL enzyme when compared with those of compound 1, which supports their in vitro data.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.